Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Estomac / intestins » Néoplasie

25. Août 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

MII (maladie de Crohn/colite)

Troubles fonctionnels

Écriture:

Page 1 de 12203


	Articles 1 - 20 / 244046

	Medicaid Expansion and Overall Mortality in Lung, Breast, and Colorectal Cancer: A Difference-in-Differences Study. Am Surg Akinyemi O, Heath JB, Oyebanji O, Fasokun M, Akinwumi B, Nnorom S, Ogunyankin F, Hughes K, Cornwell E 3rd, Levy G. PMID: 42640027 [PubMed - as supplied by publisher]
	Harmonization Framework for Translating Clinical Cancer Staging Systems for Public Health and Surveillance Use in Low- and Middle-Income Countries: Validation Using Indian Cancer Registry Data. Cancer Med Sarveswaran G, Ramraj A, Sankarapillai J, Punathil S, Mathur P. PMID: 42639990 [PubMed - indexed for MEDLINE]
	Metabolic heterogeneity and functional diversity ofÂ cancer-associated fibroblasts in gastric cancer (Review). Oncol Lett Fang Q, Lv N, Yu S, Wang J, Xin W. PMID: 42639447 [PubMed]
	Artificial intelligence applications in oxaliplatin-based chemotherapy for colon cancer: advancing prognosis, toxicity prediction, and dose personalization. Front Pharmacol Jammoul D, Ajibuwa F, Jammoul M, Schlosser-Hupf S, Müller M, El-Najjar N. PMID: 42639157 [PubMed]
	A predictive model for immunotherapy efficacy in cancer based on dynamic changes of CD8+ T cells: a pan-cancer retrospective study. Front Immunol Xie M, Wang C, Zhang J, Jing X, Ma P, Shu Y. PMID: 42639099 [PubMed - indexed for MEDLINE]
	The circadian-microbiome-immune axis in colorectal cancer: mechanisms of spatiotemporal immunosuppression and chronotherapeutic horizons. Front Immunol Li L, Wang G. PMID: 42638910 [PubMed - indexed for MEDLINE]
	Biomarker-integrated machine learning models for predicting treatment-related bowel dysfunction after rectal cancer surgery: a multicenter development and external validation study. Front Med (Lausanne) Liu Q, Liu Y, Huang Y, Fu Y, Ouyang M, Liu T, Rao J, Xia Z, Liu X, Zeng Z, Zeng J, Zeng X, Zhao S. PMID: 42638889 [PubMed]
	Targeted plasma lipidomics in non-metastatic colorectal cancer, metastatic colorectal cancer, and healthy controls: an exploratory matched-triplet study. Front Oncol Wang X, Liu H, Yin K, Liao G, Ni P, Guo J. PMID: 42638879 [PubMed]
	Cost-effectiveness analysis of triplet therapy of encorafenib, binimetinib, and cetuximab for treatment of metastatic BRAF V600E-mutated colorectal cancer in China. Front Pharmacol Liu M, Liu T. PMID: 42638785 [PubMed]
	Watch-and-wait after immunotherapy-containing neoadjuvant treatment in pMMR/MSS locally advanced rectal cancer: a multicenter real-world study. Front Immunol Luo Z, Xiang R, Shen R, Zhao H. PMID: 42638754 [PubMed - indexed for MEDLINE]
	Recurrent Peristomal Variceal Hemorrhage Secondary to Portal Hypertension: A Diagnostic Pitfall in Metastatic Rectal Cancer. Cureus Ashfaq HA, Sah A, Alnabahneh N, Frimodig B, Al-Shawk A. PMID: 42638641 [PubMed]
	Body mass index and dyslipidemia influence responses to anti-PD-1 immunotherapy in colorectal cancer. Ann Med Chen SH, Liao LE, Hou ZL, Han K, Jiang W, Ding PR, Zhang CZ. PMID: 42638413 [PubMed - indexed for MEDLINE]
	Preperation of an engineered tryptophan-depleted protein in Pichia pastoris and evaluation of its dietary anti-tumor efficacy. Sheng Wu Gong Cheng Xue Bao Dai H, Chen Y, Xie Y, Wang W, Zhou J, Chen J, Yu Y, Lin Y, Huang Y. PMID: 42638064 [PubMed - indexed for MEDLINE]
	Does the level of inferior mesenteric artery ligation affect outcomes in rectal cancer: a meta-analysis. Clin Transl Oncol Ji J, Jiang M, Wang D. PMID: 42638025 [PubMed - as supplied by publisher]
	Outcomes of laparoscopic reoperation for anastomotic leak-associated peritonitis following colorectal cancer surgery: a comparative study. Surg Endosc Ogawa K, Miyamoto Y, Kawata A, Akiyama T, Arima K, Kosumi K, Eto K, Hadara K, Hiyoshi Y, Iwatsuki M. PMID: 42637951 [PubMed - as supplied by publisher]
	Integrating CT radiomics and morphologic features for preoperative risk stratification of gastrointestinal stromal tumours. Sci Rep Denewar FA, Mansour M, Eladl AE, Denewar K, Denewer A, Abdallah A, Saleh GA. PMID: 42637794 [PubMed - indexed for MEDLINE]
	Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial. Ann Oncol Garber JE, Cameron D, Campbell C, Yothers G, Taboada M, El-Abed S, Rastogi P, McConnell R, Correa A, Delaloge S, Liu WT, Sharma P, Bergh J, Janni W, Balmaña J, Loman N, , Friedman S, Freeman T, Armstrong A, Korde L, Im S, Sagara Y, Viale G, Bliss J, Gianni L, Jóhannsson Ó, Zoppoli G, De Dueñas EM, Marmé F, Fein L, Arnedos M, Ford J, Schmutzler R, Loibl S, Linderholm B, Lakhani SR, Gnant M, Gelmon K, Domchek SM, Senkus E, Eisen A, Jager A, Piccart M, Phillips KA, Traina T, Stickeler E, Singer CF, Shao Z, Liu X, Tipping H, Aktan G, Martinez M, Canon JL, Takahashi M, Yasojima H, Middleton K, Pristauz-Telsnigg G, Pfeiler G, Virani S, Valdes-Albini F, Wolmark N, Mesa ID, Paterson V, Gelber RD, Geyer CE Jr, Tutt ANJ. PMID: 42636977 [PubMed - as supplied by publisher]
	Ifebemtinib plus garsorasib in previously treated metastatic colorectal cancer with KRAS(G12C) mutation: a multicentre, randomised, phase 1b/2 trial. Lancet Oncol Song Z, Zhu L, Liu Y, Lin R, Li X, Luo Y, Yuan Y, Shi H, Zhang Y, Zhang B, Zhu Y, Wang Z, Cheng X. PMID: 42636835 [PubMed - indexed for MEDLINE]
	Adjuvant alectinib versus chemotherapy in resected ALK-positive non-small-cell lung cancer (ALINA): health-related quality-of-life and safety outcomes from a randomised, open-label, phase 3 trial. Lancet Oncol Dziadziuszko R, Ahn JS, Barlesi F, Solomon BJ, Wu YL, Bondarenko I, Hochmair M, Horinouchi H, Lee DH, Lee JS, Planchard D, Rittmeyer A, Zhong W, Adler L, Archer V, Cardona A, Petric P, Scalori A, Ding B, Mamolo C, Smoljanovic V, Nishio M. PMID: 42636834 [PubMed - indexed for MEDLINE]
	Ivonescimab plus chemotherapy versus placebo plus chemotherapy in patients with advanced EGFR-mutated non-small-cell lung cancer after disease progression on EGFR tyrosine kinase inhibitor therapy (HARMONi): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol Le X, Passaro A, Zhao Y, Huang Y, Laskin J, Rodriguez-Abreu D, Calles A, Bazhenova L, Lo Russo G, Leighl NB, Cappuzzo F, Girard N, Popat S, Fang W, Luo Y, Li W, He Z, Zhao H, Li M, Song Q, Zhao H, El Darsa H, Monnet I, Cobo Dols M, García Campelo R, Jotte R, Berz D, Spira A, Pérol M, Nagasaka M, West H, Styles L, Li J, Clow F, Goldman J, Zhang L. PMID: 42636833 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 244046

Page 1 de 12203



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité